Literature DB >> 11171594

Parathyroid hormone induces hepatic production of bioactive interleukin-6 and its soluble receptor.

M A Mitnick1, A Grey, U Masiukiewicz, M Bartkiewicz, L Rios-Velez, S Friedman, L Xu, M C Horowitz, K Insogna.   

Abstract

Interleukin-6 (IL-6) is an important mediator of parathyroid hormone (PTH)-induced bone resorption. Serum levels of IL-6 and its soluble receptor (IL-6sR) are regulated in part by PTH. The PTH/PTH-related protein type 1 receptor is highly expressed in the liver, and in the current study we investigated whether the liver produces IL-6 or IL-6sR in response to PTH. Perfusion of the isolated rat liver with PTH-(1-84) stimulated rapid, dose-dependent production of bioactive IL-6 and the IL-6sR. These effects were observed at near physiological concentrations of the hormone such that 1 pM PTH induced hepatic IL-6 production at a rate of approximately 0.6 ng/min. In vitro, hepatocytes, hepatic endothelial cells, and Kupffer cells, but not hepatic stellate cells, were each found to produce both IL-6 and IL-6sR in response to higher (10 nM) concentrations of PTH. Our data suggest that hepatic-derived IL-6 and IL-6sR contribute to the increase in circulating levels of these cytokines induced by PTH in vivo and raise the possibility that PTH-induced, liver-derived IL-6 may exert endocrine effects on tissues such as bone.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11171594     DOI: 10.1152/ajpendo.2001.280.3.E405

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  19 in total

1.  Proteoglycan 4: a dynamic regulator of skeletogenesis and parathyroid hormone skeletal anabolism.

Authors:  Chad M Novince; Megan N Michalski; Amy J Koh; Benjamin P Sinder; Payam Entezami; Matthew R Eber; Glenda J Pettway; Thomas J Rosol; Thomas J Wronski; Ken M Kozloff; Laurie K McCauley
Journal:  J Bone Miner Res       Date:  2012-01       Impact factor: 6.741

2.  25-hydroxyvitamin D, parathyroid hormone, and functional recovery after hip fracture in elderly patients.

Authors:  Marco Di Monaco; Fulvia Vallero; Roberto Di Monaco; Rosa Tappero; Alberto Cavanna
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

3.  Calcium supplementation does not affect CRP levels in postmenopausal women--a randomized controlled trial.

Authors:  A Grey; G Gamble; R Ames; A Horne; B Mason; I R Reid
Journal:  Osteoporos Int       Date:  2006-05-30       Impact factor: 4.507

4.  Aging and bone loss: new insights for the clinician.

Authors:  Oddom Demontiero; Christopher Vidal; Gustavo Duque
Journal:  Ther Adv Musculoskelet Dis       Date:  2012-04       Impact factor: 5.346

5.  Relation of serum phosphorus levels to carotid intima-media thickness in asymptomatic young adults (from the Bogalusa Heart Study).

Authors:  Litao Ruan; Wei Chen; Sathanur R Srinivasan; Jihua Xu; Ahmet Toprak; Gerald S Berenson
Journal:  Am J Cardiol       Date:  2010-08-02       Impact factor: 2.778

6.  De novo autoimmune hepatitis associated with PTH(1-34) and PTH(1-84) administration for severe osteoporosis in a liver transplant patient.

Authors:  P Anagnostis; Z A Efstathiadou; E Akriviadis; P Hytiroglou; M Kita
Journal:  Osteoporos Int       Date:  2011-11-26       Impact factor: 4.507

7.  Short-term infusion of interleukin-6 does not induce insulin resistance in vivo or impair insulin signalling in rats.

Authors:  V Rotter Sopasakis; B-M Larsson; A Johansson; A Holmäng; U Smith
Journal:  Diabetologia       Date:  2004-11-17       Impact factor: 10.122

8.  Race-specific associations of 25-hydroxyvitamin D and parathyroid hormone with cardiometabolic biomarkers among US white and black postmenopausal women.

Authors:  Jin Xia; Wanzhu Tu; JoAnn E Manson; Hongmei Nan; Aladdin H Shadyab; Jennifer W Bea; Ting-Yuan D Cheng; Lifang Hou; Yiqing Song
Journal:  Am J Clin Nutr       Date:  2020-08-01       Impact factor: 7.045

9.  Endothelial function and endothelial nitric oxide synthase intron 4a/b polymorphism in primary hyperparathyroidism.

Authors:  A Ekmekci; N Abaci; N Colak Ozbey; A Agayev; N Aksakal; H Oflaz; N Erginel-Unaltuna; Y Erbil
Journal:  J Endocrinol Invest       Date:  2009-07-02       Impact factor: 4.256

10.  Inflammatory markers in end-stage renal disease patients on haemodialysis.

Authors:  Phebe Lotfy Abdel-Messeih; Manal Mohamed Alkady; Neveen Mostafa Nosseir; Mohamed Said Tawfik
Journal:  J Med Biochem       Date:  2020-10-02       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.